1.
Gatenby RA,
Grove O,
Gillies RJ.
Quantitative imaging in cancer evolution and ecology.
Radiology.
2013 Oct;269(1):8-15.
2.
Bashir U,
Siddique MM,
Mclean E,
Goh V,
Cook GJ.
Imaging Heterogeneity in Lung Cancer: Techniques,
Applications,
and Challenges.
AJR Am J Roentgenol.
2016 Sep;207(3):534-43.
3.
Lambin P,
Leijenaar RTH,
Deist TM,
Peerlings J,
de Jong EEC,
van Timmeren J,
Sanduleanu S,
Larue RTHM,
Even AJG,
Jochems A,
van Wijk Y,
Woodruff H,
van Soest J,
Lustberg T,
Roelofs E,
van Elmpt W,
Dekker A,
Mottaghy FM,
Wildberger JE,
Walsh S.
Radiomics: the bridge between medical imaging and personalized medicine.
Nat Rev Clin Oncol.
2017 Dec;14(12):749-762.
4.
Larue RT,
Defraene G,
De Ruysscher D,
Lambin P,
van Elmpt W.
Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures.
Br J Radiol.
2017 Feb;90(1070):20160665.
5.
Grossmann P,
Stringfield O,
El-Hachem N,
Bui MM,
Rios Velazquez E,
Parmar C,
Leijenaar RT,
Haibe-Kains B,
Lambin P,
Gillies RJ,
Aerts HJ.
Defining the biological basis of radiomic phenotypes in lung cancer.
Elife.
2017 Jul 21;6.
6.
Ganeshan B,
Goh V,
Mandeville HC,
Ng QS,
Hoskin PJ,
Miles KA.
Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.
Radiology.
2013 Jan;266(1):326-36.
7.
Chae HD,
Park CM,
Park SJ,
Lee SM,
Kim KG,
Goo JM.
Computerized texture analysis of persistent part-solid ground-glass nodules: differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas.
Radiology.
2014 Oct;273(1):285-93.
8.
Weiss GJ,
Ganeshan B,
Miles KA,
Campbell DH,
Cheung PY,
Frank S,
Korn RL.
Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
PLoS One.
2014 Jul 2;9(7):e100244.
9.
Ozkan E,
West A,
Dedelow JA,
Chu BF,
Zhao W,
Yildiz VO,
Otterson GA,
Shilo K,
Ghosh S,
King M,
White RD,
Erdal BS.
CT Gray-Level texture analysis as a quantitative imaging biomarker of epiderma growth factor receptor mutation status in adenocarcinoma of the lung. AJR Am J Roentgenol.
2015 Nov;205(5):1016-25.
10.
Yoon RG,
Seo JB,
Kim N,
Lee HJ,
Lee SM,
Lee YK,
Song JW,
Song JW,
Kim DS.
Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system.
Eur Radiol.
2013 Mar;23(3):692-701.
11.
Dennie C,
Thornhill R,
Sethi-Virmani V,
Souza CA,
Bayanati H,
Gupta A,
Maziak D.
Role of quantitative computed tomography texture analysis in the differentiation of primary lung cancer and granulomatous nodules.
Quant Imaging Med Surg.
2016 Feb;6(1):6-15.
12.
Hawkins S,
Wang H,
Liu Y,
Garcia A,
Stringfield O,
Krewer H,
Li Q,
Cherezov D,
Gatenby RA,
Balagurunathan Y,
Goldgof D,
Schabath MB,
Hall L,
Gillies RJ.
Predicting Malignant Nodules from Screening CT Scans.
J Thorac Oncol.
2016 Dec;11(12):2120-2128.
13.
Gao X,
Chu C,
Li Y,
Lu P,
Wang W,
Liu W,
Yu L.
The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancer.
Eur J Radiol.
2015 Feb;84(2):312-7.
14.
Bayanati H,
E Thornhill R,
Souza CA,
Sethi-Virmani V,
Gupta A,
Maziak D,
Amjadi K,
Dennie C.
Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer?.
Eur Radiol.
2015 Feb;25(2):480-7.
15.
Ganeshan B,
Panayiotou E,
Burnand K,
Dizdarevic S,
Miles K.
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.
Eur Radiol.
2012 Apr;22(4):796-802.
16.
Aerts HJ,
Velazquez ER,
Leijenaar RT,
Parmar C,
Grossmann P,
Carvalho S,
Bussink J,
Monshouwer R,
Haibe-Kains B,
Rietveld D,
Hoebers F,
Rietbergen MM,
Leemans CR,
Dekker A,
Quackenbush J,
Gillies RJ,
Lambin P.
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
Nat Commun.
2014 Jun 3;5:4006.
17.
Huang Y,
Liu Z,
He L,
Chen X,
Pan D,
Ma Z,
Liang C,
Tian J,
Liang C.
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Radiology.
2016 Dec;281(3):947-957.
18.
Mattonen SA,
Palma DA,
Johnson C,
Louie AV,
Landis M,
Rodrigues G,
Chan I,
Etemad-Rezai R,
Yeung TP,
Senan S,
Ward AD.
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Int J Radiat Oncol Biol Phys.
2016 Apr 1;94(5):1121-8.
19.
Ravanelli M,
Farina D,
Morassi M,
Roca E,
Cavalleri G,
Tassi G,
Maroldi R.
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy.
Eur Radiol.
2013 Dec;23(12):3450-5.
20.
Cook GJ,
O'Brien ME,
Siddique M,
Chicklore S,
Loi HY,
Sharma B,
Punwani R,
Bassett P,
Goh V,
Chua S.
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.
Radiology.
2015 Sep;276(3):883-93.